Search clinical trials for: Comparator: etoricoxib

Total 2082 results

Clinical Nutrition Research Center, Illinois Institute...

Completed

Dose-dependent Effect of Grape Seed Extract on Glucose Control in People With Impaired Glucose Tolerance (GSE3)

Impaired Glucose Tolerance

United States
Organon and Co

Completed

Study of the Bioequivalence of the 20% and 30% Etoricoxib Tablet Formulations (0663-070)

Pain
Organon and Co

Completed

Rheumatoid Arthritis Dose Ranging Study (0663-086)(COMPLETED)

Rheumatoid Arthritis
Ludwig-Maximilians - University of Munich
Merck Sharp & Dohme LLC

Terminated

Etoricoxibe - Preemptive and Postoperative Analgesia for Abdominal and Thoracic Surgery (EPPA)

Pain | Abdominal Surgery | Thoracic Surgery

Germany
Eurofarma Laboratorios S.A.

Withdrawn

Fixed-dose Combination of Etoricoxib + Cyclobenzaprine for Pain Relief After Third Molar Extraction in Brazil (BENCOX)

Third Molar Extraction

Brazil
Organon and Co

Completed

An Investigational Drug Study in the Treatment of Primary Dysmenorrhea (0663-064)

Dysmenorrhea
Organon and Co

Completed

A Study of MK0663/Etoricoxib for Post-Abdominal Hysterectomy Surgery Pain (0663-097)(COMPLETED)

Acute Pain Following a Total Abdominal Hysterectomy
Organon and Co

Completed

A Study to Asses the Effect of MK0663 in the Treatment of Patients With Postoperative Dental Pain (0663-092)

Postoperative Dental Pain
Organon and Co

Completed

A Study of MK0663 and an Approved Drug in the Treatment of Osteoarthritis (0663-077)(COMPLETED)

Osteoarthritis
Organon and Co

Completed

The Single Dose Pharmacokinetics of Two and Proof of Efficacy of One New Etoricoxib Gel Formulation in Participants With Osteoarthritis (MK-0663-168)

Osteoarthritis Pain
Organon and Co

Completed

Investigational Drug Versus an Approved Drug in Patients With Osteoarthritis (0663-061)(COMPLETED)

Osteoarthritis
Organon and Co

Completed

A Study to Evaluate the Safety of an Investigational Drug (Etoricoxib) in Patients With Osteoarthritis (OA) or Rheumatoid Arthritis (RA)(0663-066)

Rheumatoid Arthritis,Osteoarthritis
Organon and Co

Completed

Investigational Drug Versus an Approved Drug in Patients With Rheumatoid Arthritis (0663-072)

Rheumatoid Arthritis
Organon and Co

Completed

A Two-Part 26-Week Study of Etoricoxib as Treatment for Ankylosing Spondylitis (AS) (MK-0663-108)

Spondylitis, Ankylosing
Organon and Co

Completed

A Study of MK0663 and an Approved Drug in the Treatment of Osteoarthritis (0663-076)(COMPLETED)

Osteoarthritis
Organon and Co

Completed

A Two-Part, 12-Week Study of Etoricoxib as a Treatment for Rheumatoid Arthritis (RA) (MK-0663-107)

Arthritis, Rheumatoid
Organon and Co

Completed

Effect of Etoricoxib to Treat Chronic Low Back Pain (0663-042)

Recurrent Low Back Pain
Organon and Co

Completed

Effect of Etoricoxib to Treat Chronic Low Back Pain (0663-041)

Recurrent Low Back Pain
Organon and Co

Completed

An Investigational Drug in Patients With Osteoarthritis (0663-073)

Osteoarthritis
Organon and Co

Completed

Etoricoxib vs. Diclofenac in OA (0663-805)(COMPLETED)

Osteoarthritis
Radboud University Medical Center

Completed

Prevention of Heterotopic Ossification With Arcoxia After Total Hip Replacement (Arcoxia)

Ossification, Heterotopic

Netherlands
Organon and Co

Completed

Study of MK0663 in Patients With Chronic Low Back Pain (0663-806)(COMPLETED)

Chronic Low Back Pain
Organon and Co

Completed

A Study to Assess Etoricoxib Versus Diclofenac in Chinese Patients With Osteoarthritis of the Knee or Hip (0663-080)(COMPLETED)

Osteoarthritis
Organon and Co

Completed

Study of MK-0663/Etoricoxib in Postorthopedic Knee Replacement Surgery Pain (MK-0663-098)

Pain, Postoperative
Clinica Virgen Milagrosa
Merck Sharp & Dohme LLC

Terminated

Etoricoxib in Acute Soft Tissue Rheumatism Affecting the Shoulder

Soft Tissue Injuries of the Shoulder | Tenosynovitis and Bursitis Affecting the Shoulder

Peru
Eisai Inc.

Completed

A Randomized, Double-blind, Placebo-controlled, Combined Single Ascending Dose and Multiple Ascending Dose Study

Alzheimer's Disease

United States
Núcleo de Estudos em Esportes e Ortopedia, Brazil
Merck Sharp & Dohme LLC

Unknown

Efficacy and Safety of Etoricoxib in Acute Ankle Sprain: A Double-Blind Comparative Study Among 2 Treatments Protocols

Sprains and Strains | Contusions

Brazil
University of Erlangen-Nürnberg Medical School
Merck Sharp & Dohme LLC; Rush University Medical Center; HELIOS Kliniken GmbH

Terminated

Modulation of the Surgical Inflammatory Response by Etoricoxib

Pain | Postoperative Pain | Osteoarthritis, Hip

Germany
Merck Sharp & Dohme LLC

Withdrawn

A Study to Assess the Effects of MK0822 in Reducing the Risk of Bone Metastasis in Women With Breast Cancer (0822-029)

Breast Cancer
Merck Sharp & Dohme LLC

Terminated

The Efficacy and Safety of MK0724 IV for Improvement of Neurological Damage and Recovery From Middle Cerebral Artery Ischemic Stroke (0724-018)

Middle Cerebral Artery Stroke
TiumBio Co., Ltd.

Recruiting

TUC3PII-01_TU2670 Phase IIa Clinical Study

Endometriosis

Czechia, Italy, Russian Federation, Poland, Ukraine
Organon and Co

Completed

A Study Evaluating the Effect of Etoricoxib and Indomethacin in the Treatment of Acute Gout (0663-081)(COMPLETED)

Acute Gout
Merck Sharp & Dohme LLC

Terminated

A Multiple-Dose Study of MK-1006 (MK-1006-004)(TERMINATED)

Type 2 Diabetes
University of Sao Paulo

Completed

Analgesic Effect of Etoricoxib (ARCOXIA®) 120MG During Retinal Laser Photocoagulation

Proliferative Diabetic Retinopathy

Brazil
Cognition Therapeutics

Recruiting

Study to Evaluate the Efficacy and Safety of Oral CT1812 in Participants With Geographic Atrophy (GA) Secondary to Dry Age-Related Macular Degeneration (AMD).

Age-Related Macular Degeneration

United States
Merck Sharp & Dohme LLC

Completed

A Study of the Safety and Efficacy of MK-0773 in Women With Sarcopenia (Loss of Muscle Mass)(MK-0773-005)

Sarcopenia
Merck Sharp & Dohme LLC

Completed

A Clinical Study to Determine Biomarkers of Response to a Gamma Secretase Inhibitor

Healthy
Merck Sharp & Dohme LLC

Completed

Study the Safety and Effectiveness of MK7009 in Hepatitis C Infected Patients (MK-7009-004)(COMPLETED)

Hepatitis C
United States Naval Medical Center, San Diego

Terminated

Low -vs- High-Frequency Repetitive TMS of the Right Dorsolateral Prefrontal Cortex in PTSD

PTSD - Post Traumatic Stress Disorder
Merck Sharp & Dohme LLC

Terminated

A Study of the Safety and Immune Response to RotaTeq™ Vaccine in the Elderly (V260-027)

Rotavirus
Darnitsa Pharmaceutical Company
Anapharm Bioanalytics

Completed

Bioequivalence Study of Test and Reference 120 mg Etoricoxib Film-coated Tablets in Healthy Volunteers

Healthy Subjects | Bioequivalence

Turkey
Guangzhou JOYO Pharma Co., Ltd

Recruiting

SC1011 Twice Daily vs Placebo in Patients Diagnosed With Idiopathic Pulmonary Fibrosis (IPF)

Idiopathic Pulmonary Fibrosis

China
AbbVie

Withdrawn

Study to Assess Adverse Events When Subcutaneous Risankizumab Injection is Given to Adult Participants With Psoriasis in Real World Setting

Psoriasis
Clinical Nutrition Research Center, Illinois Institute...

Completed

Acute Effects of Coffee Beverage on Postprandial Inflammation and Oxidative Stress - A Pilot Study (COF1)

Healthy | Overweight | Obese

United States
Merck Sharp & Dohme LLC

Completed

A Single-Dose Study of the Safety, Tolerability, and Pharmacokinetics of Odanacatib (MK0822) in Healthy Volunteers

Osteoporosis
Merck Sharp & Dohme LLC

Completed

Concomitant Use of Gardasil (V501) (Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diphtheria, Tetanus, Pertussis Vaccine and Meningococcal Conjugate Vaccine in Adolescents (V501-025)

Neoplasms, Glandular and Epithelial | Whooping Cough | Tetanus | Diphtheria | Meningitis
Gadjah Mada University

Recruiting

Adductor Canal Block in Outpatient Clinic for Pain Control After Knee Arthroplasty (ACB)

Acute Pain | Total Knee Arthroplasty

Indonesia
Merck Sharp & Dohme LLC

Completed

Hepatitis B Vaccine Booster Study (V232-058)(COMPLETED)

Hepatitis B
Merck Sharp & Dohme LLC

Completed

A Study to Assess the Effects of Exenatide on Insulin Secretion Rates Using a Graded Infusion of Intravenous Glucose (0000-099)(COMPLETED)

Healthy
C4Pain
Merck Sharp & Dohme LLC

Completed

A Single Center 2-way Crossover Study to Investigate the Mechanism of Action of Etoricoxib in Subjects With Osteoarthritis Knee Pain

Osteoarthritis

Denmark

3

Subscribe